<DOC>
	<DOCNO>NCT02207374</DOCNO>
	<brief_summary>This trial conduct Asia . The aim trial investigate safety efficacy semaglutide weekly monotherapy combination one OAD ( oral anti-diabetic drug ) Japanese subject type 2 diabetes insufficiently control diet/exercise therapy OAD monotherapy . All subject continue pre-trial treatment ( diet exercise therapy OAD monotherapy addition diet exercise therapy ) trial .</brief_summary>
	<brief_title>A Trial Comparing Safety Efficacy Semaglutide Once Weekly Monotherapy Combination With One OAD Japanese Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Dipeptidyl-Peptidase IV Inhibitors</mesh_term>
	<criteria>Male female , age least 20 year time signing informed consent HbA1c ( glycosylated haemoglobin A1c ) 7.0 % 10.5 % ( 5391 mmol/mol ) ( inclusive ) Japanese subject type 2 diabetes mellitus ( diagnose clinically ) stable treatment ( define unchanged medication unchanged dose ) : ) diet exercise therapy least 30 day Visit 1 ( week 2 ) . b ) OAD monotherapy ( either SU ( sulfonylurea ) , glinide , aGI ( aglucosidase inhibitor ) TZD ( thiazolidinediones ) ) within approve Japanese label addition diet exercise therapy least 60 day Visit 1 ( week 2 ) Female pregnant , breastfeed intend become pregnant childbearing potential use adequate contraceptive method ( e.g. , abstinence [ sex ] , diaphragm , condom [ partner ] , intrauterine device , sponge , spermicide oral contraceptive ) throughout trial include 5 week followup period Treatment glucose lower agent ( ) state inclusion criterion within 60 day Visit 1 ( week 2 ) treatment weekly glucagonlike peptide1 ( GLP1 ) receptor agonist within 90 day Visit 1 ( week 2 ) . An exception shortterm treatment ( equal 7 day total ) insulin connection intercurrent illness Any disorder , opinion investigator , might jeopardise subject 's safety compliance protocol History chronic idiopathic acute pancreatitis Screening calcitonin value equal 50 ng/L ( pg/mL ) Personal family history medullary thyroid carcinoma ( MTC ) multiple endocrine neoplasia syndrome type 2 ( MEN2 ) Impaired renal function define estimate glomerular filtration rate ( eGFR ) 30 mL/min/1.73 m^2 per modification diet renal disease ( MDRD ) formula ( 4 variable version ) Acute coronary cerebrovascular event within 90 day randomisation ( Visit 2 [ week 0 ] ) Heart failure , New York Heart Association ( NYHA ) class IV</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>